73 related articles for article (PubMed ID: 2831821)
1. [Phase II studies of a single agent and a cis-platinum-based two-drug combination in patients with non-small cell lung cancer].
Yamamoto M; Furuse K; Fukuoka M; Kawahara M; Arai R; Kodama N; Takada M; Negoro S; Matsui K; Ryu S
Gan To Kagaku Ryoho; 1988 Mar; 15(3):487-92. PubMed ID: 2831821
[TBL] [Abstract][Full Text] [Related]
2. [Current results of chemotherapy in non-small cell lung cancer].
Fukuoka M; Negoro S; Takada M; Matsui K; Takifuji N; Masuda N; Kawahara M; Furuse K
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):203-9. PubMed ID: 2162439
[TBL] [Abstract][Full Text] [Related]
3. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
Furuse K; Fukuoka M; Asamoto H; Niitani H; Kimura I; Sakuma A; Yamaguchi Y
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
[TBL] [Abstract][Full Text] [Related]
4. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Haneda H; Koizumi M; Hayashi T
Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer].
Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Imajou K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3295-300. PubMed ID: 2825603
[TBL] [Abstract][Full Text] [Related]
6. Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
Lelli G; Casadio M; Giuliotti C; Giordani S; Martoni A; Strocchi E; Pannuti F
Chemioterapia; 1986 Aug; 5(4):228-31. PubMed ID: 3021346
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
8. [Cis-dichlorodiammine platinum (II) CDDP in the treatment of non-small cell lung cancer].
Eguchi K; Shimizu E; Saijo N; Sasaki Y; Shinkai T; Tominaga K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1764-9. PubMed ID: 6541021
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
Nakano H; Kurihara M; Saito R; Takise A; Tsuchiya S; Minato K; Takehara K; Saruya T; Kuwabara H; Fueki R
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2123-7. PubMed ID: 3013099
[TBL] [Abstract][Full Text] [Related]
11. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
Huisman C; Biesma B; Postmus PE; Giaccone G; Schramel FM; Smit EF
Br J Cancer; 2001 Nov; 85(10):1456-61. PubMed ID: 11720428
[TBL] [Abstract][Full Text] [Related]
12. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
Recchia F; Sica G; De Filippis S; Rea S; Frati L
Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
Wang YM; Guo LJ; Li LS; Li P; Zheng J; Li L
Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of chemotherapy of unresectable non-small cell lung cancer].
Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kawakami K; Mishima M; Kuno K
Gan To Kagaku Ryoho; 1992 Jan; 19(1):55-60. PubMed ID: 1309632
[TBL] [Abstract][Full Text] [Related]
16. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
Mantovani G; Macciò A; Mulas C; Massa E; Madeddu C; Mura L; Contu P; Versace R
Oncol Rep; 2002; 9(3):661-70. PubMed ID: 11956647
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy of CDDP and etoposide in advanced non-small cell carcinoma of the lung].
Kodama N; Furuse K; Kawahara M; Arai R; Yamamoto M; Tsuruta M; Kubota K; Ogawara M; Nakai R; Kawano S
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3233-7. PubMed ID: 2848457
[TBL] [Abstract][Full Text] [Related]
18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
20. [Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
Uchida J; Satake H; Saito H; Nakano K; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1001-8. PubMed ID: 8210249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
